Back to Agenda
Session 3: Panel Discussion - Meeting Regional Disclosure Requirements while Aiming for a Global Standard
Session Chair(s)
Merete Joergensen, MBA, MSC
Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark
While disclosure of clinical trials information must meet national/regional legislation requirements, the information is accessed and used in a global world. Standardised information is supporting transparency by providing consistent information. How might a global standard be developed, and maintained? What are the challenges seen from the registry owners and the industry who are providing the information
Speaker(s)
Panelist
Barbara Godlew, RN
Eli Lilly and Company, United States
Associate Consultant, Scientific Communications, GSC-Bio-Medicines
Panelist
Deborah A. Zarin, DrMed, MD
MRCT Center, United States
Faculty, Harvard Medical Center; Program Director
Panelist
Hanns-Georg Leimer, PHD
Boehringer Ingelheim Pharma GmbH&CO KG, Germany
Global Head Central Solutions and Services Medicine (CSSM) in Global Biostatisti
Have an account?